PLA2G4A
protein-codingphospholipase A2 group IVA, the group of Phospholipases|C2 domain containing phospholipases
Gene summary
This gene encodes a member of the cytosolic phospholipase A2 group IV family. The enzyme catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid which is subsequently metabolized into eicosanoids. Eicosanoids, including prostaglandins and leukotrienes, are lipid-based cellular hormones that regulate hemodynamics, inflammatory responses, and other intracellular pathways. The hydrolysis reaction also produces lysophospholipids that are converted into platelet-activating factor. The enzyme is activated by increased intracellular Ca(2+) levels and phosphorylation, resulting in its translocation from the cytosol and nucleus to perinuclear membrane vesicles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
- PLA2G4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~160.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0018794
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0018794
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018794
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0018794
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0018794
Submitter: ClinGen
PLA2G4A was first reported in relation to autosomal recessive cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder in 2008 (Adler DH, et al., 2008, PMID: 18451993). At least four unique variants (3 missense and 1 intronic) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least three probands in three publications (PMIDs: 18451993, 23268370, 25102815). Variants in this gene segregated with disease in two additional family members. This gene-disease relationship is supported by its biochemical function in the release of arachidonic acid (PMID: 3143418), functional alteration in both patient (PMID: 26183771) and non-patient cells (PMID: 21247147), and a mouse model (PMID: 12163563). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was orginally evaluated by the HT GCEP on 03/25/2020 and reevaluated on 06/22/2022. It was again reevaluated on 10/21/2024 and as a result of this reevaluation the classification did not change as no new information is contributing to the classification.
Inheritance Pattern: AR
Disease ID:MONDO:0018765
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Hematologic
Intervention: Gastrointestinal; Hematologic
Rationale: Surveillance for bleeding complications may be beneficial, as a described individual had chronic GI blood loss from childhood, with multiple small intestinal ulcers discovered in the context of severe bleeding and perforations during adulthood; Awareness of GI complications, including Cryptogenic multifocal ulcerating stenosing enteritis, as has been described in one pair of siblings, may allow early medical and/or surgical management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PLA2G4A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_024420.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 65 | 3 | 68 | |||
| missense | 3 | 59 | 7 | 3 | 72 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 4 | 2 | 63 | 72 | 6 | 147 |
Highest pathogenic variant AF is 0.0000027364686
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_077734.2 | 17 | MANE Select | |
| Ensembl | ENSP00000356436.3 | 17 | MANE Select | |
| RefSeq | NP_001298122.2 | 15 | Standard | |
| Ensembl | ENSP00000521173.1 | 17 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| pla2g4aa | Danio rerio | Structure: otic vesicle Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Inflammatory mediator regulation of TRP channels - Homo sapiens (human)
- Platelet activation - Homo sapiens (human)
- Oxytocin signaling pathway - Homo sapiens (human)
- Fc epsilon RI signaling pathway - Homo sapiens (human)
- Fc gamma R-mediated phagocytosis - Homo sapiens (human)
Biological Process
- phospholipid metabolic process
- phosphatidic acid biosynthetic process
- platelet activating factor biosynthetic process
- icosanoid metabolic process
- arachidonic acid metabolic process
Molecular Function
- lysophospholipase activity
- phospholipase A2 activity
- calcium ion binding
- calcium-dependent phospholipid binding
- phospholipase A1 activity
Cellular Component
- nucleus
- cytoplasm
- mitochondrial inner membrane
- endoplasmic reticulum
- endoplasmic reticulum membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367466
- Coding exons
- 17
- Length
- 160029
- Individuals with no LoFs
- 125719
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 29
- Defined
- 125748
- p
- 0.000115
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.35 | 265 | 397 | 0.667 | 0.0000198 | 5027 |
| Missense (PolyPhen) | 66 | 151.3 | 0.43621 | 1950 | ||
| Synonymous | -0.0493 | 137 | 136 | 1.01 | 0.00000724 | 1338 |
| Loss of Function | 3.53 | 14 | 37.3 | 0.376 | 0.00000195 | 464 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00037 | 0.00037 | rare |
| European (Non-Finnish) | 0.000071 | 0.000070 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response.;
- Disease
- DISEASE: Note=PLA2G4A mutations resulting in phospholipase A2 deficiency have been found in a patient affected by recurrent episodes of multiple complicated ulcers of the small intestine, not due to cyclooxygenase inhibitors use. Disease features also include platelet dysfunction, and globally decreased eicosanoid synthesis (PubMed:18451993). {ECO:0000269|PubMed:18451993}.;
Recessive Scores
- pRec
- 0.448
Intolerance Scores
- LoFtool
- 0.642
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.99
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.945
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |